Synergistic suppression of rat neointimal hyperplasia by rapamycin and imatinib mesylate: implications for the prevention of accelerated arteriosclerosis. [electronic resource]
- Journal of vascular research 2006
- 184-92 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1018-1172
10.1159/000090948 doi
Angioplasty, Balloon--adverse effects Animals Aorta, Abdominal--injuries Arteriosclerosis--prevention & control Benzamides Drug Synergism Hyperplasia--prevention & control Imatinib Mesylate Male Piperazines--therapeutic use Protein-Tyrosine Kinases--antagonists & inhibitors Pyrimidines--therapeutic use Rats Rats, Wistar Sirolimus--pharmacokinetics